Rating History for Intellia Therapeutics (NTLA) by William Blair
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/2/2026 | Myles Minter | Upgrade | Outperform (Market Perform) |
N/A (N/A) |
13.78 (15.25) |
10.67% | Details |
 |
|||||||
|
|||||||
